Association of functional kallikrein-1 promoter polymorphisms and acute kidney injury: A case-control and longitudinal cohort study

Nephron - Clinical Practice

Volumn 122, Issue 3-4, 2012, Pages 107-113

  Susantitaphong, Paweena ^a,b   Perianayagam, Mary C ^a   Kang, Sun Woo ^c,d   Zhang, Wenyi ^c   Rao, Fangwen ^c   O'Connor, Daniel T ^c   Jaber, Bertrand L ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d Inje University   (South Korea)

Author keywords

Acute kidney injury; Gene; Kallikrein 1; Polymorphism; Promoter

Indexed keywords

TISSUE KALLIKREIN; GENETIC MARKER;

ACUTE KIDNEY FAILURE; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; PROMOTER REGION; RISK ASSESSMENT; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; ACUTE KIDNEY INJURY; CLINICAL TRIAL;

ACUTE KIDNEY INJURY; ADULT; AGE DISTRIBUTION; AGED; BOSTON; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROMOTER REGIONS, GENETIC; RISK ASSESSMENT; SEX DISTRIBUTION; TISSUE KALLIKREINS;

EID: 84876809691     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000350733     Document Type: Article

References (36)

1. Hsu CY, McCulloch CE, Fan D, Ordonez JD, Chertow GM, Go AS: Community-based incidence of acute renal failure. Kidney Int 2007; 72: 208-212
2. Hospitalization discharge diagnoses for kidney disease-United States, 1980-2005. MMWR Morb Mortal Wkly Rep 2008; 57: 309-312
3. Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG: Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 2009; 302: 1179-1185
4. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR: Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 961-973
5. Lewis J, Salem MM, Chertow GM, Weisberg LS, McGrew F, Marbury TC, Allgren RL: Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 2000; 36: 767-774
6. Friedrich JO, Adhikari N, Herridge MS, Beyene J: Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005; 142: 510-524
7. Jaber BL, Pereira BJ, Bonventre JV, Balakrishnan VS: Polymorphism of host response genes: implications in the pathogenesis and treatment of acute renal failure. Kidney Int 2005; 67: 14-33
8. Haase-Fielitz A, Haase M, Bellomo R, Dragun D: Genetic polymorphisms in sepsis-and cardiopulmonary bypass-associated acute kidney injury. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 75-91
9. Haase-Fielitz A, Haase M, Bellomo R, Lambert G, Matalanis G, Story D, Doolan L, Buxton B, Gutteridge G, Luft FC, et al: Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol 2009; 20: 1393-1403
10. Alam A, O'Connor DT, Perianayagam MC, Kolyada AY, Chen Y, Rao F, Mahata M, Mahata S, Liangos O, Jaber BL: Phenylethanolamine N-methyltransferase gene polymorphisms and adverse outcomes in acute kidney injury. Nep hron Clin Pract 2010; 114:c253-c259
11. Perianayagam MC, Liangos O, Kolyada AY, Wald R, MacKinnon RW, Li L, Rao M, Balakrishnan VS, Bonventre JV, Pereira BJ, et al: NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007; 18: 255-263
12. Kolyada AY, Tighiouart H, Perianayagam MC, Liangos O, Madias NE, Jaber BL: A genetic variant of hypoxia-inducible factor-1? is associated with adverse outcomes in acute kidney injury. Kidney Int 2009; 75: 1322-1329
13. Jaber BL, Rao M, Guo D, Balakrishnan VS, Perianayagam MC, Freeman RB, Pereira BJ: Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 2004; 25: 212-219
14. Yousef GM, Diamandis EP: The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev 2001; 22: 184-204
15. Song CK, Martinez JA, Kailasam MT, Dao TT, Wong CM, Parmer RJ, O'Connor DT: Renal kallikrein excretion: role of ethnicity, gender, environment, and genetic risk of hypertension. J Hum Hypertens 2000; 14: 461-468
16. Bodin S, Chollet C, Goncalves-Mendes N, Gardes J, Pean F, Heudes D, Bruneval P, Marre M, Alhenc-Gelas F, Bouby N: Kallikrein protects against microalbuminuria in experimental type I diabetes. Kidney Int 2009; 76: 395-403
17. Ardiles LG, Figueroa CD, Mezzano SA: Renal kallikrein-kinin system damage and salt sensitivity: insights from experimental models. Kidney Int Suppl 2003;86:S2-S8
18. Higa EM, Schor N, Boim MA, Ajzen H, Ramos OL: Role of the prostaglandin and kallikrein-kinin systems in aminoglycoside-induced acute renal failure. Braz J Med Biol Res 1985; 18: 355-365
19. Chao J, Zhang JJ, Lin KF, Chao L: Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats. Kidney Int 1998; 54: 1250-1260
20. Bledsoe G, Crickman S, Mao J, Xia CF, Murakami H, Chao L, Chao J: Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Nephrol Dial Transplant 2006; 21: 624-633
21. Bledsoe G, Shen B, Yao YY, Hagiwara M, Mizell B, Teuton M, Grass D, Chao L, Chao J: Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury. Toxicol Sci 2008; 102: 433-443
22. Kang SW, Shih PA, Mathew RO, Mahata M, Biswas N, Rao F, Yan L, Bouchard J, Malhotra R, Tolwani A, et al: Renal kallikrein excretion and epigenetics in human acute kidney injury: expression, mechanisms and consequences. BMC Nephrol 2011; 12: 27
23. Song Q, Chao J, Chao L: DNA polymorphisms in the 5 -flanking region of the human tissue kallikrein gene. Hum Genet 1997; 99: 727-734
24. Lee-Chen GJ, Liu KP, Lai YC, Juang HS, Huang SY, Lin CY: Significance of the tissue kallikrein promoter and transforming growth factor- 1 polymorphisms with renal progression in children with vesicoureteral reflux. Kidney Int 2004; 65: 1467-1472
25. Yu H, Song Q, Freedman BI, Chao J, Chao L, Rich SS, Bowden DW: Association of the tissue kallikrein gene promoter with ESRD and hypertension. Kidney Int 2002; 61: 1030-1039
26. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256
27. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829
28. Knaus WA, Wagner DP: Multiple systems organ failure: epidemiology and prognosis. Crit Care Clin 1989; 5: 221-232
29. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
30. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31
31. Zhang L, Rao F, Wessel J, Kennedy BP, Rana BK, Taupenot L, Lillie EO, Cockburn M, Schork NJ, Ziegler MG, et al: Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins. Physiol Genomics 2004; 19: 277-291
32. O'Connor DT, Barg AP, Amend W, Vincenti F: Urinary kallikrein excretion after renal transplantation: relationship to hypertension, graft source, and renal function. Am J Med 1982; 73: 475-481
33. Funaki N, Kuroda M, Sudo J, Takeda R: Urinary prostaglandins and kallikrein in the course of acute renal failure. Prostaglandins Leukot Med 1982; 9: 387-399
34. Basile DP, Fredrich K, Alausa M, Vio CP, Liang M, Rieder MR, Greene AS, Cowley AW Jr: Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. Am J Physiol Renal Physiol 2005; 288:F953-F963
35. Hagiwara M, Shen B, Chao L, Chao J: Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hum Gene Ther 2008,19: 807-819
36. Tu L, Xu X, Wan H, Zhou C, Deng J, Xu G, Xiao X, Chen Y, Edin ML, Voltz JW, et al: Delivery of recombinant adeno-associated virusmediated human tissue kallikrein for therapy of chronic renal failure in rats. Hum Gene Ther 2008; 19: 318-330.